Lindsey Roeker, MD
Leukemia Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Richter’s Transformation
- Lymphoproliferative Disorders
Request an Appointment
About Me
- Assistant Attending Physician
I am a hematologist and medical oncologist with expertise in leukemia, including chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Richter’s transformation, and lymphoproliferative disorders. I am deeply committed to partnering with my patients and their families through every stage of their cancer journey while delivering high-quality, thoughtful care.
Read more
As a clinical researcher and member of the CLL program at Memorial Sloan Kettering Cancer Center, I develop and lead clinical trials that bring cutting-edge treatments to patients with CLL/SLL and Richter’s transformation. Along with a team of dedicated doctors, nurses, and scientists, I am working to move the field forward with innovative approaches, including novel agents and immunotherapies.
I am deeply invested in providing care for the whole person, and I understand the profound impact that cancer diagnosis can have on a person’s life — including their emotional and physical health. I strive to communicate clearly and honestly as I work with each individual to tailor a treatment plan that honors their priorities.
A leukemia specialist is a doctor with special training in diagnosing and treating leukemia.
My Specialties
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Richter’s Transformation
- Lymphoproliferative Disorders
Education
- MD, Mayo Clinic School of Medicine
Residencies
- Internal Medicine - Brigham and Women’s Hospital
Awards and Honors
- Research Training Award for Fellows, American Society of Hematology (2019)
- Chief Fellow, Memorial Sloan Kettering Cancer Center (2018-2019)
- John Mendelsohn Housestaff Teaching Award, Memorial Sloan Kettering Cancer Center (2018)
- Resident Mentor Award, Brigham and Women’s Hospital (2017)
Fellowships
- Hematology and Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Roeker sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Roeker
- A Phase 1 Study of DZD8586 in People With B-Cell Non-Hodgkin Lymphoma
- A Phase III Study Assessing Early versus Delayed Treatment with Venetoclax and Obinutuzumab for Newly Diagnosed Patients with High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma without Symptoms
- A Study Assessing Minimal Residual Disease to Minimize Side Effects in People with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Were Treated with Venetoclax
- Clinical Trials Co-Investigated by Dr. Roeker
- A Phase 1 Study of ABBV-525 in People With B-Cell Lymphoma
Read more
- A Phase 1 Study of NX-5948 in People With B-Cell Lymphoma/Leukemia
- A Phase I Study of BGB-16673 in People with B Cell Cancers
- A Phase I Study of Epcoritamab in People with Relapsed or Persistent Chronic Lymphocytic Leukemia
- A Phase IB Study of Mosunetuzumab in People with Recurrent or Persistent Chronic Lymphocytic Leukemia
- A Phase II Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Roeker’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Lindsey Roeker discloses the following relationships and financial interests:
-
AbbVie
Professional Services and Activities -
Ascentage Pharma
Professional Services and Activities (Uncompensated) -
AstraZeneca
Professional Services and Activities -
BeiGene, Ltd.
Professional Services and Activities -
Dava Oncology
Professional Services and Activities -
Genentech
Professional Services and Activities -
Karger Publishers
Professional Services and Activities -
Lilly Oncology
Professional Services and Activities
-
Loxo Oncology
Professional Services and Activities -
MJH Life Sciences
Professional Services and Activities -
OncLive
Professional Services and Activities -
PeerView Institute for Medical Education (PVI)
Professional Services and Activities -
Pharmacyclics
Professional Services and Activities -
Red Med Ed LLC
Professional Services and Activities -
Research to Practice
Professional Services and Activities -
Vaniam Group
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].